42 CHEMIN DES OLIVETTES, 34160 SAINT-GENIES-DES-MOURGUES
| Type | Language | Name |
|---|---|---|
| Official name | FR | TRANSPHARM |
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Net income for the year | €206,563 35% | €319,525 8% | €349,201 24% | €280,698 |
| Equity | €669,243 22% | €862,680 4% | €833,155 33% | €626,954 |
| Balance sheet total | €1,038,917 14% | €1,215,027 19% | €1,020,021 21% | €843,966 |
Revenue, ratios (solvency, debt, ROE), interactive charts and full history — available in your dashboard.
Source: RNE / INPI (filed annual accounts) · Updated on June 21, 2026
TRANSPHARM is registered in the SIRENE directory under SIREN number 407 758 523.
TRANSPHARM's registered office is located at 42 CHEMIN DES OLIVETTES, 34160 SAINT-GENIES-DES-MOURGUES.
TRANSPHARM operates under the activity “Recherche-développement en biotechnologie” (NAF/APE code 72.11Z).
Full analysis: finances, establishments, directors, history — in your dashboard.
TRANSPHARM's intra-EU VAT number, derived from its SIREN, is FR 45 407 758 523. Whether it is actually active depends on the company being liable for VAT.
TRANSPHARM has the following legal form: SAS, société par actions simplifiée (5710).
TRANSPHARM was created on June 4, 1996.
Yes, TRANSPHARM is an active company according to the SIRENE / INSEE directory.
TRANSPHARM has 3 establishments in the SIRENE directory, of which 1 active.